U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: October 13-19, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: October 13-19, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 10/15/2024
Location: New York, NY
Subject: Dean's Distinguished Lecture Series; Fireside Chat: Academic Medical Centers to Improve Health Outcomes and Maintaining the Health of Residents
FDA Participant/Group: COURTNEY BUCHANAN;
Non FDA Participant/Group: Several Weill Cornell Medicine faculty and students, hospital leaders, research leaders, and other invited attendees

Event Date: 10/16/2024
Location: Ithaca, NY
Subject: One Health and Emergent Threat Preparedness
FDA Participant/Group: JAMES JONES; TRISTAN COLONIUS;
Non FDA Participant/Group: Industry, academia, and other invited attendees

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 10/15/2024
Location: Ithaca, NY
Subject: Produce Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Elizabeth A. Bihn, Laura Acuna Maldonado (Department of Food Science at Cornell University and the Produce Safety Alliance);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 10/14/2024
Location: New Delhi, India
Subject: 19th International Conference of Drug Regulatory Authorities; Panelist: Smart Regulation: The New Era of World Health Organization (WHO) Listed Authority (WLA) and Increased Reliance
FDA Participant/Group: JOHN WEINER;
Non FDA Participant/Group: Industry, academia, government, and other stakeholders

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/16/2024
Location: Silver Spring, MD
Subject: Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub: A Conversation with The Rare Disease Innovation Hub Co-Directors
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Rare disease industry, research, and patient advocate stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/14/2024
Location: Virtual
Subject: University of Pennsylvania Summit; Fireside Chat: In Vivo Gene Therapy and Genome Editing
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and academic stakeholders

Event Date: 10/15/2024
Location: Virtual
Subject: Laguna Biotech CEO Conference; Panelist: Novel Medicine Development at Warp Speed
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Event Date: 10/17/2024
Location: Virtual
Subject: FDA-Biotechnology Innovation Organization Liaison Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the Biotechnology Innovation Organization

Event Date: 10/19/2024
Location: Virtual
Subject: University of Southern California Department of Regulatory and Quality Sciences’ Chemistry, Manufacturing, and Controls Course; Cell and Gene Therapy: Innovations, Safety, Regulations
FDA Participant/Group: N/A
Non FDA Participant/Group: University of Southern California School of Pharmacy faculty, staff, and students

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 10/14/2024
Location: Toronto, Canada
Subject: The Medtech Conference 2024; 12th Annual Symposium on Pediatric Device Innovation: Closing Keynote Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry stakeholders, and members of the public

Event Date: 10/15/2024
Location: Toronto, Canada
Subject: AdvaMed Board of Directors' Meeting
FDA Participant/Group: JEFFREY SHUREN;
Non FDA Participant/Group: AdvaMed leadership

Event Date: 10/16/2024
Location: Toronto, Canada
Subject: The Medtech Conference 2024; Panelist: Best Practices for Incorporating Diverse Patient Perspectives in Patient-Centered Design and Regulatory Decision Making
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry stakeholders, and members of the public

Event Date: 10/17/2024
Location: Toronto, Canada
Subject: The Medtech Conference 2024; Speaker: Vision to Implementation: Diversification of Clinical Evidence
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry stakeholders, and members of the public

Event Date: 10/17/2024
Location: Toronto, Canada
Subject: AdvaMed: Town Hall
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry stakeholders, and members of the public

Event Date: 10/17/2024
Location: Chicago, IL
Subject: American Academy of Opthalmology (AAO) Annual Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the American Academy for Opthalmology

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 10/17/2024
Location: Philadelphia, PA
Subject: 12th Annual Clearing the Air Institute Conference; Speaker: U.S. Regulation of Flavored Tobacco Products, An Update from FDA’s Center for Tobacco Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives of the American Nonsmokers' Rights Foundation and conference attendees

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

 

Back to Top